Close
Smartlab Europe
Achema middle east

Press Releases

DFE Pharma expands its inhalation portfolio with the launch of Lactohale® 400

DFE Pharma, a global leader in pharma- and nutraceutical excipient solutions, announced the expansion of its Dry Powder Inhalation (DPI) portfolio with the launch of Lactohale® 400. The addition of Lactohale® 400 further enhances the completeness of DFE Pharma’s portfolio...

Topping-out ceremony for the world’s first AI-enhanced drug production facility

Bayer AG celebrated the topping-out ceremony for a new pharmaceutical plant in Leverkusen/Germany in the presence of German Chancellor Olaf Scholz, German Health Minister Professor Dr Karl Lauterbach and other guests from politics and industry. The new Solida 1...

Airnov to showcase its range of healthcare packaging solutions to Indian market at Innopack Pharma Confex

Airnov Healthcare Packaging, a global leader in controlled atmosphere packaging, will be presenting a large portfolio of solutions available to customers in India at the upcoming Innopack Pharma Confex, scheduled to take place in Mumbai on June 9-10. Now in...

Vetter Achieves a Three-Peat in Winning the Best Managed Companies Award

For the third year in a row, Vetter, a globally leading contract development and manufacturing organization (CDMO), has won the Best Managed Companies Award. With this three-win feat, the pharmaceutical service provider has once again demonstrated why it is...

Croda announces the new Pharma business

Croda has announced that its Health Care division will now become Croda Pharma, bringing its core speciality excipient portfolio together with the recent acquisition, Avanti Polar Lipids and its Adjuvant Systems arm, all under one business. Croda Pharma has seen...

N4 Pharma highlights potential of Nuvec as gene therapy delivery platform

A pre-clinical in-vivo study found that Nuvec® – N4 Pharma’s novel silica-based nanoparticle – formulated with TNF-α pDNA oncotherapy, suppressed tumour growth and improved survival of treated mice compared to untreated controls. This research has added to growing evidence of...

Aptamer Group signs deal with Flip Gene Therapeutics to support the development of inducible gene therapies

Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, has negotiated a deal with the biotechnology company Flip Gene Therapeutics to support its novel, inducible gene therapy platform with the use...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »